1. Home
  2. WVVI vs ALXO Comparison

WVVI vs ALXO Comparison

Compare WVVI & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVVI
  • ALXO
  • Stock Information
  • Founded
  • WVVI 1983
  • ALXO 2015
  • Country
  • WVVI United States
  • ALXO United States
  • Employees
  • WVVI N/A
  • ALXO N/A
  • Industry
  • WVVI Beverages (Production/Distribution)
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WVVI Consumer Staples
  • ALXO Health Care
  • Exchange
  • WVVI Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • WVVI 29.5M
  • ALXO 24.0M
  • IPO Year
  • WVVI N/A
  • ALXO 2020
  • Fundamental
  • Price
  • WVVI $5.85
  • ALXO $0.58
  • Analyst Decision
  • WVVI
  • ALXO Strong Buy
  • Analyst Count
  • WVVI 0
  • ALXO 6
  • Target Price
  • WVVI N/A
  • ALXO $3.30
  • AVG Volume (30 Days)
  • WVVI 5.1K
  • ALXO 445.9K
  • Earning Date
  • WVVI 05-13-2025
  • ALXO 05-08-2025
  • Dividend Yield
  • WVVI N/A
  • ALXO N/A
  • EPS Growth
  • WVVI N/A
  • ALXO N/A
  • EPS
  • WVVI N/A
  • ALXO N/A
  • Revenue
  • WVVI $38,520,945.00
  • ALXO N/A
  • Revenue This Year
  • WVVI N/A
  • ALXO N/A
  • Revenue Next Year
  • WVVI N/A
  • ALXO N/A
  • P/E Ratio
  • WVVI N/A
  • ALXO N/A
  • Revenue Growth
  • WVVI N/A
  • ALXO N/A
  • 52 Week Low
  • WVVI $3.17
  • ALXO $0.41
  • 52 Week High
  • WVVI $6.33
  • ALXO $9.40
  • Technical
  • Relative Strength Index (RSI)
  • WVVI 47.15
  • ALXO 60.39
  • Support Level
  • WVVI $5.78
  • ALXO $0.52
  • Resistance Level
  • WVVI $5.99
  • ALXO $0.59
  • Average True Range (ATR)
  • WVVI 0.12
  • ALXO 0.04
  • MACD
  • WVVI 0.00
  • ALXO 0.02
  • Stochastic Oscillator
  • WVVI 28.00
  • ALXO 94.10

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: